Nisa Investment Advisors LLC Has $24.77 Million Stock Holdings in CME Group Inc. (NASDAQ:CME)

Nisa Investment Advisors LLC raised its position in CME Group Inc. (NASDAQ:CME) by 10.1% during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 112,259 shares of the financial services provider’s stock after acquiring an additional 10,302 shares during the period. Nisa Investment Advisors LLC’s holdings in CME Group were worth $24,770,000 as of its most recent filing with the SEC.

A number of other large investors have also recently bought and sold shares of the company. Capital International Investors grew its holdings in shares of CME Group by 24.1% in the 1st quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock valued at $3,403,557,000 after acquiring an additional 3,069,806 shares in the last quarter. Ameriprise Financial Inc. grew its stake in CME Group by 11.3% in the second quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider’s stock valued at $1,038,676,000 after purchasing an additional 537,758 shares in the last quarter. GUARDCAP ASSET MANAGEMENT Ltd increased its position in shares of CME Group by 1.1% during the 1st quarter. GUARDCAP ASSET MANAGEMENT Ltd now owns 4,009,068 shares of the financial services provider’s stock worth $863,112,000 after purchasing an additional 43,293 shares during the last quarter. Raymond James & Associates raised its stake in shares of CME Group by 3.2% during the 2nd quarter. Raymond James & Associates now owns 3,029,145 shares of the financial services provider’s stock worth $595,530,000 after purchasing an additional 94,302 shares in the last quarter. Finally, Legal & General Group Plc boosted its holdings in shares of CME Group by 6.6% in the 2nd quarter. Legal & General Group Plc now owns 2,835,075 shares of the financial services provider’s stock valued at $557,371,000 after buying an additional 176,004 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have issued reports on CME. Keefe, Bruyette & Woods upped their price target on shares of CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a research report on Thursday, July 25th. Morgan Stanley raised their price objective on CME Group from $210.00 to $233.00 and gave the company an “equal weight” rating in a research report on Thursday, October 17th. TD Cowen started coverage on CME Group in a research note on Thursday, September 26th. They issued a “hold” rating and a $221.00 price target on the stock. Piper Sandler upped their price objective on shares of CME Group from $240.00 to $250.00 and gave the company an “overweight” rating in a report on Monday. Finally, JPMorgan Chase & Co. lifted their target price on shares of CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a report on Thursday, July 25th. Four equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $222.73.

Insider Buying and Selling

In other news, CFO Lynne Fitzpatrick sold 754 shares of the firm’s stock in a transaction that occurred on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the sale, the chief financial officer now directly owns 13,261 shares in the company, valued at approximately $2,877,504.39. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other news, CFO Lynne Fitzpatrick sold 754 shares of the company’s stock in a transaction on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total transaction of $163,610.46. Following the completion of the transaction, the chief financial officer now directly owns 13,261 shares in the company, valued at approximately $2,877,504.39. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the transaction, the director now owns 55,607 shares of the company’s stock, valued at $11,932,706.13. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.30% of the stock is owned by corporate insiders.

CME Group Stock Up 0.9 %

CME stock opened at $228.12 on Tuesday. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $230.36. The business has a 50-day simple moving average of $219.32 and a 200 day simple moving average of $208.98. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.10. The company has a market cap of $82.14 billion, a PE ratio of 25.95, a price-to-earnings-growth ratio of 7.76 and a beta of 0.55.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, topping analysts’ consensus estimates of $2.65 by $0.03. The company had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.59 billion. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The firm’s quarterly revenue was up 18.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.25 EPS. Sell-side analysts anticipate that CME Group Inc. will post 10.04 EPS for the current fiscal year.

CME Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th were paid a $1.15 dividend. The ex-dividend date was Monday, September 9th. This represents a $4.60 annualized dividend and a dividend yield of 2.02%. CME Group’s payout ratio is 52.33%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.